How will Oxford vaccine be made in India? Exclusive peek inside Serum Institute's Covishield plant
3 years, 11 months ago

How will Oxford vaccine be made in India? Exclusive peek inside Serum Institute's Covishield plant

India Today  

Covishield, the Covid-19 vaccine developed by Pune-based Serum Institute of India and AstraZeneca-Oxford University is on verge of getting emergency approval in India for distribution among at-risk personnel. The institute’s CEO Adar Poonawalla took Rahul Kanwal for an exclusive walkabout around the Covishield factory to show and explain the process behind the production of the Covid vaccine. Adar Poonawalla said that every person would need to get two doses of vaccine for effective results. Adar Poonawalla said that the Serum Institute has set two separate rates of the vaccine - one for the Government of India and one for the private sector. Serum Institute CEO Adar Poonwalla said that all vaccines are bound to have some side-effects which manifest in a small percentage of people who get the vaccine.

Vaccines Institute Oxford Serum Doses Poonawalla Adar Serum Institute Covishield Sii Covishield Vaccine Two Doses Other Vaccines Rahul Kanwal Vaccine Vials India Exclusive  poonawalla  institutes  institute  doses  inside  oxford  india  exclusive  vaccines  peek  serum  adar  plant  vaccine  vials  covishield

History of this topic

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
7 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

Stopped manufacturing Covishield since December 2021, says Serum Institute
7 months, 2 weeks ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times  

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

With State prod, India can be world leader in vaccines
10 months, 4 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Serum Institute of India to produce 5mn Covishield doses in two months
1 year, 8 months ago

Serum Institute of India to produce 5mn Covishield doses in two months

Hindustan Times  

Serum Institute of India chief executive officer Adar Poonawalla, while underlining that the current strain of Covid is mild and the demand for vaccine shots is low, said his firm will produce five to six million Covishield doses in the next two to three months and same amount of stock is already available for Covovax. According to Poonawalla, SII has …

Serum Institute could resume Covishield production as Covid cases rise
1 year, 8 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint  

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla
2 years ago

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla

The Hindu  

Serum Institute of India CEO Adar Poonawalla on Tuesday expressed concern over reports of a rising COVID-19 graph in China but said there is no need to panic as the vaccination coverage in India is excellent. Mr. Poonawalla's tweet came a day after the Union Health Ministry urged all states and UTs to ramp up the whole genome sequencing of …

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
2 years ago

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal

Deccan Chronicle  

Hyderabad: Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate. The company sources said Bharat Biotech is currently holding discussions with international “potential partners” who have approached the company for manufacturing and distribution of the intranasal vaccine globally. “Since iNCOVACC has …

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership
2 years, 5 months ago

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership

News 18  

India has crossed record 200 crore mark in Covid-19 vaccinations within 18 months of launching the inoculation exercise in January last year. #200CroreVaccinations https://t.co/FtobFYBprV— Dr Mansukh Mandaviya July 17, 2022 A seven-phase vaccination drive was followed on the principle of Prioritization for Vaccine Administration based on scientific advice and global best practices, government officials told News18. While some experts had …

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence
2 years, 5 months ago

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence

News 18  

With the UK-India week on the cusp, it becomes pertinent to discuss how the United Kingdom and India have weathered rough storms during the pandemic years to come out closer than ever. It is this three-way partnership that has now been at the helm of having already delivered over 2 billion affordable, effective vaccines which have now been administered to …

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO
2 years, 8 months ago

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO

Hindustan Times  

Chief executive officer of Serum Institute of India Adar Poonawalla on Tuesday said the company has a stockpile of 200 million doses of Covishield, while it has already exported 40 million doses of Covovax to European countries and Australia. Serum Institute of India CEO Adar Poonawalla speaks at the 'AIMA Leadership Conclave' in New Delhi on Tuesday, "We have a …

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference
2 years, 8 months ago

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference

News 18  

A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India told the Centre on Sunday that it will compensate for the price difference for the unexpired stocks lying with private centres in the form of free vials of fresh stocks, official sources said. Vaccine majors …

Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age group
2 years, 10 months ago

Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age group

Deccan Chronicle  

New Delhi: Biological E has sought emergency use authorisation from India's drug regulator for its COVID-19 vaccine Corbevax for the 12 to 18 years age group, official sources said on Sunday. The Drugs Controller General Of India has already approved Corbevax, which is India's first indigenously developed RBD protein sub-unit vaccine against COVID-19, for restricted use in emergency situation among …

Centre Places Purchase Order For 5 Crore Doses Of Corbevax Covid-19 Vaccine: Report
2 years, 10 months ago

Centre Places Purchase Order For 5 Crore Doses Of Corbevax Covid-19 Vaccine: Report

ABP News  

New Delhi: The Central Government has placed an order with Hyderabad-based Pharmaceutical business Biological E for five crore doses of the 'Corbevax' COVID-19 vaccine, with each dosage costing Rs 145, according to the reports. “In this regard, it is also stated that Rs 1,500 crores has been released as advance vide sanction order dated June 2, 2021, to HLL Lifecare …

Panel pitches full market nod for Covaxin, Covishield
2 years, 11 months ago

Panel pitches full market nod for Covaxin, Covishield

Hindustan Times  

The subject expert panel of the national drugs regulator on Wednesday recommended full market authorisation for both Covaxin and Covishield under certain conditions, according to people familiar with the developments. Serum Institute of India and Bharat Biotech International Ltd, manufacturers of Covishield and Covaxin respectively, separately applied to the central drugs standard control organisation to seek full market authorisation stating …

SEC recommends Covaxin, Covishield for full market authorisation: Report
2 years, 11 months ago

SEC recommends Covaxin, Covishield for full market authorisation: Report

Hindustan Times  

The subject expert committee of the Central Drugs Standard Control Organisation on Wednesday recommended regular market approval for Covaxin and Covishield, the two most widely used jabs in the national vaccination drive against Covid-19, news agency PTI has reported, citing official sources. The development comes just days after the SEC, on January 14, sought more data from the two manufacturers--Hyderabad-based …

India's Covid-19 vaccination drive, one year on | Recap
2 years, 11 months ago

India's Covid-19 vaccination drive, one year on | Recap

India Today  

One year ago, India set out on the challenging journey of vaccinating its massive 1.38 billion-strong population against Covid-19. In the year since the country’s vaccination drive began, 90 per cent of the eligible population has received the first dose and 60 per cent has got their second dose too. More than 156 crore vaccine doses have been administered in …

Give full authorisation to Covishield: Serum Institute of India
2 years, 11 months ago

Give full authorisation to Covishield: Serum Institute of India

Hindustan Times  

NEW DELHI: Pune-based Serum Institute of India on Friday announced it has applied to India’s drugs regulator for full market authorisation to Covishield, its anti-Covid vaccine, citing adequate availability of the required data. The government of India now has enough data for full market authorisation, and therefore @SerumInstIndia has applied to the @CDSCO_INDIA_INF and @MoHFW_INDIA for this permission,” Adar Poonawalla, …

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield
2 years, 11 months ago

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield

Firstpost  

SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government, which had in January this year granted emergency use authorisation in the country. New Delhi: Serum Institute of India CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market authorisation of Covishield, stating supplies …

Covishield could soon be available at medical stores as SII seeks full market authorisation nod
2 years, 11 months ago

Covishield could soon be available at medical stores as SII seeks full market authorisation nod

India TV News  

Pune-based Serum Institute of India has applied for full market authorisation for the COVID-19 vaccine Covishield with the drug regulator. SII CEO Adar Poonawala confirmed that the institute has applied for full market authorisation of the drug, stating supplies of the COVID-19 vaccine have exceeded 125 crore doses. The institute had earlier this month sought the drug regulator's approval for …

Maximising the boost: The Hindu Editorial on mixing COVID-19 vaccines
2 years, 11 months ago

Maximising the boost: The Hindu Editorial on mixing COVID-19 vaccines

The Hindu  

Heralding a new frontier in India’s vaccination programme, the apex drug regulator has approved two more vaccines under emergency use authorisation, and an antiviral drug. Despite three vaccines being available, India has overwhelmingly been reliant on Covishield and that is a matter of concern as a new chapter in the vaccination programme unfolds. The new directives say that “precaution doses”, …

Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022
2 years, 11 months ago

Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022

News 18  

Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the city-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday. “Biological E. Limited plans to complete production at a …

Covishield: Oxford-Astrazeneca vaccine remained effective even during India’s brutal second wave
3 years ago

Covishield: Oxford-Astrazeneca vaccine remained effective even during India’s brutal second wave

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy The Covishield vaccine was effective …

Serum Institute seeks DCGI nod for Covid vaccine Covovax
3 years, 1 month ago

Serum Institute seeks DCGI nod for Covid vaccine Covovax

India Today  

The Serum Institute of India on Friday sought permission from the Drugs Controller General of India to manufacture Covid-19 vaccine Covovax for restricted use in emergency situations at its Manjari manufacturing site, official sources said. There were no safety concerns arising from the study data and Covovax is safe and immunogenic in the adult population, Prakash Kumar Singh, Director, Government …

Awaiting Govt Nod on Exports, Won't Rush Vaccine for Kids: Adar Poonawalla - News18
3 years, 2 months ago

Awaiting Govt Nod on Exports, Won't Rush Vaccine for Kids: Adar Poonawalla - News18

News 18  

Pune-based Serum Institute of India could export 2 to 3 crore Covid-19 vaccine doses to WHO-backed COVAX by November and December, the company’s chief Adar Poonawalla told News18.com. The manufacturer of Covishield, the vaccine which became the backbone of India’s vaccination drive against Covid-19, SII has boosted its production capacity to 22 crore doses per month. “That said, based on …

Coal crisis | No shortage of anything; reports baseless: FM Nirmala Sitharaman
3 years, 2 months ago

Coal crisis | No shortage of anything; reports baseless: FM Nirmala Sitharaman

The Hindu  

Amid reports of the ongoing coal shortage in the country, Finance Minister Nirmala Sitharaman stressed that there is no shortage and termed these as “absolutely baseless”, saying India is a power surplus country. Ms. Sitharaman said that Power Minister R.K. Singh went on record just two days ago when he said absolutely baseless information is floating around that there is …

WHO 'Deeply Concerned' Over Covid Vaccines Approved for Emergency Use Not Being Recognised in All Countries: Official
3 years, 2 months ago

WHO 'Deeply Concerned' Over Covid Vaccines Approved for Emergency Use Not Being Recognised in All Countries: Official

News 18  

The World Health Organisation is deeply concerned that COVID-19 vaccines that have proven to be effective and have been approved by the global health body for emergency use are not being recognised in all countries, an official said on Thursday. Addressing a press briefing, Dr Bruce Aylward, Senior Advisor to WHO Director General Dr Tedros Adhanom Ghebreyesus, said the organisation …

WHO 'deeply concerned' over Covid vaccines approved for emergency use not being recognised in all countries
3 years, 2 months ago

WHO 'deeply concerned' over Covid vaccines approved for emergency use not being recognised in all countries

India TV News  

The World Health Organisation is “deeply concerned” that COVID-19 vaccines that have proven to be effective and have been approved by the global health body for emergency use are not being recognized in all countries, an official said on Thursday. Addressing a press briefing, Dr. Bruce Aylward, Senior Advisor to WHO Director-General Dr. Tedros Adhanom Ghebreyesus, said the organization again …

UK recognises Indian vaccine certificate: No quarantine for Covishield-vaccinated travellers from Oct 11
3 years, 2 months ago

UK recognises Indian vaccine certificate: No quarantine for Covishield-vaccinated travellers from Oct 11

India Today  

On Thursday, UK announced that fully vaccinated Indian travellers will no longer have to quarantine on entering the country. Alex Ellis, British High Commissioner to India, posted from his official Twitter handle, "No quarantine for Indian travellers to UK fully vaccinated with Covishield or another UK-approved vaccine from 11 October. No quarantine for Indian travellers to UK fully vaccinated with …

UK Updates Travel Advisory for Those Going to India Day After 'Tit-for-Tat' Move
3 years, 2 months ago

UK Updates Travel Advisory for Those Going to India Day After 'Tit-for-Tat' Move

News 18  

The UK government on Saturday updated its official advisory for its nationals travelling to India following New Delhi’s decision to impose reciprocal curbs on the British visitors from Monday, and said it was in close contact with Indian authorities on the issue. The updated travel advisory by the UK Foreign, Commonwealth and Development Office noted an additional COVID-19 test on …

Centre received 65.25 crore Covishield doses, 9.1 crore Covaxin doses till September 19
3 years, 2 months ago

Centre received 65.25 crore Covishield doses, 9.1 crore Covaxin doses till September 19

India Today  

According to official documents, the Government of India received over 65.25 crore Covishield doses from Serum Institute of India and 9.1 crore doses of Covaxin from Bharat Biotech till September 19. Pune-based Serum Institute supplied 20.29 lakh doses of Covishield to the Union Ministry of Health in September as committed by Prakash Kumar Singh, the company's director of government and …

UK's Stand on Indian Vaccine Certificates is Arbitrary, Reeks of Colonial Bias
3 years, 3 months ago

UK's Stand on Indian Vaccine Certificates is Arbitrary, Reeks of Colonial Bias

News 18  

It has been 74 years since the British were forced to leave India, but the colonial hangover continues. He said at a media briefing the next day that India could think of “reciprocal measures” against the nations which don’t recognize our country’s vaccine certification. A British High Commission spokesperson said after the earlier rejection raised a firestorm in India: “We …

Covishield gets UK nod, but Indians still have to quarantine. The dispute, explained
3 years, 3 months ago

Covishield gets UK nod, but Indians still have to quarantine. The dispute, explained

Hindustan Times  

The United Kingdom is facing a severe backlash for what many have called its “selective vaccine policy” after the country issued its revised international travel advisory on Wednesday, in which it approved several formulations of the coronavirus disease vaccine – including the Covishield shot manufactured by the Serum Institute. However, even though the UK kept Covishield, manufactured by the SII, …

Nod to Covishield, Not to CoWIN Certificate: UK's Another Slip Between the Cup and the Lip
3 years, 3 months ago

Nod to Covishield, Not to CoWIN Certificate: UK's Another Slip Between the Cup and the Lip

News 18  

After backlash from the Indian diaspora, UK on Wednesday revised its travel advisory and included Covishield in its list of accepted vaccines butIndians will have to quarantine and get tested on arrival as Britain still does not accept CoWIN certificate. Earlier, reacting to the decision, India’s foreign secretary Harsh Vardhan Shringla, had called the UK government’s decision to not recognise …

UK recognises Covishield but quarantine rule for vaccinated Indians to continue
3 years, 3 months ago

UK recognises Covishield but quarantine rule for vaccinated Indians to continue

India Today  

The United Kingdom has announced changes in its travel and quarantine rules and said that the UK now recognises Covishield as a vaccine. In its latest travel update, the UK has said that from October 4, one will qualify as fully vaccinated if they are “vaccinated under an approved vaccination programme in the UK, Europe, USA or UK vaccine programme …

India considers ‘reciprocal’ steps to U.K.’s quarantine rules
3 years, 3 months ago

India considers ‘reciprocal’ steps to U.K.’s quarantine rules

The Hindu  

India could impose “reciprocal measures” on the United Kingdom if London maintained the current quarantine policy that subjected Indian travellers “irrespective of vaccination status” to a quarantine period lasting 10 days, Foreign Secretary Harsh Vardhan Shringla said here on Tuesday. The comments came hours after External Affairs Minister S. Jaishankar met his British counterpart Liz Truss in New York on …

India warns of 'reciprocal measures' over UK's decision not to recognise Covishield vaccine certificate
3 years, 3 months ago

India warns of 'reciprocal measures' over UK's decision not to recognise Covishield vaccine certificate

Firstpost  

The new rules, which also require people arriving from many other countries to undergo quarantine, have sparked anger in India New Delhi: India on Tuesday criticised the British government’s decision not to recognise coronavirus vaccine certificates issued by Indian authorities, calling it a “discriminatory policy” that will impact its citizens who want to travel to that country. Foreign Secretary Harsh …

Why UK faces heat from India over its 'unvaccinated' status for Covishield users
3 years, 3 months ago

Why UK faces heat from India over its 'unvaccinated' status for Covishield users

Firstpost  

As per United Kingdom’s new travel rules, Indians who have been administered Covishield – the bioequivalent of ‘Vaxzevria’ – the Oxford-AstraZeneca vaccine – will not be considered vaccinated and will have to undergo quarantine for 10 days The latest changes in the United Kingdom government’s COVID-19-related travel restrictions has renewed controversy over freedom of international travel during the pandemic. The …

Serum Institute of India to supply nearly 22 cr doses of Covishield to Centre in October
3 years, 3 months ago

Serum Institute of India to supply nearly 22 cr doses of Covishield to Centre in October

India Today  

The Serum Institute of India has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Union government has announced resuming export of surplus Covid vaccines in the coming fourth quarter under the 'Vaccine Maitri' programme, official sources said. In a communication to the Centre on Monday, Prakash Kumar Singh, …

Biological E’s Corbevax may be launched in October: Niti Aayog’s VK Paul
3 years, 3 months ago

Biological E’s Corbevax may be launched in October: Niti Aayog’s VK Paul

Hindustan Times  

Hyderabad-based pharmaceutical company Biological E may launch its vaccine, ‘Corbevax’, against the coronavirus disease in October with phase three trial underway. In June, the Union health ministry had said Biological E would supply 30 crore doses of Corbevax to India by December. On Wednesday, the Drug Controller General of India gave permission to Biological E to conduct phase 2/3 clinical …

How Goes India’s Covid Vaccine Production? Here’s a Look at the Numbers
3 years, 4 months ago

How Goes India’s Covid Vaccine Production? Here’s a Look at the Numbers

News 18  

With Johnson and Johnson‘s single-dose Covid-19 vaccine getting approval for emergency use, India now has five vaccines to offer to its citizens. Before Johnson & Johnson, India’s drug regulator DCGI had over a month ago granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country. As India gets another vaccine added …

Adar Poonawalla meets Health Minister Mansukh Mandaviya, discusses ramping up Covishield supply
3 years, 4 months ago

Adar Poonawalla meets Health Minister Mansukh Mandaviya, discusses ramping up Covishield supply

India TV News  

The Union Health Minister Mansukh Mandaviya held a meeting with Serum Institute of India CEO Adar Poonawalla on Friday. I appreciated their role in mitigating #COVID19 & assured continued Government support in ramping up vaccine production," said the Health Minister in a tweet. Earlier, the Centre said in Parliament, "As communicated by the manufacturers, the monthly vaccine production capacity of …

Adar Poonawalla sets aside Rs 10 crore to support students travelling abroad
3 years, 4 months ago

Adar Poonawalla sets aside Rs 10 crore to support students travelling abroad

India TV News  

Serum Institute of India CEO and owner Adar Poonawalla on Thursday said that he has set aside Rs 10 crore to support students travelling abroad for studies, as a few countries are yet to approve Covishield as an acceptable vaccine for entry without quarantine. "Dear students travelling abroad, as a few countries are yet to approve Covishield as an acceptable …

Good News: Adar Poonawalla after 16 European nations recognise Covishield
3 years, 5 months ago

Good News: Adar Poonawalla after 16 European nations recognise Covishield

India TV News  

Chief Executive Officer and owner of the Serum Institute of India on Saturday said that it was good news for international travellers that Covishield, the Indian version of the Oxford-Astrazeneca vaccine was now recognised and accepted by 16 European countries. “It is indeed good news for travellers, as we see sixteen European countries recognising Covishield as an acceptable vaccine for …

Serum Institute's Covishield vaccine gets nod from France for travel
3 years, 5 months ago

Serum Institute's Covishield vaccine gets nod from France for travel

Firstpost  

The move to accept visitors vaccinated with AstraZeneca’s vaccine made by SII came after a global outcry over the fact that the EU’s selective approval was discriminatory Paris: France will allow international travelers who have had AstraZeneca’s Indian-manufactured vaccine into the country starting Sunday. The move to accept visitors vaccinated with AstraZeneca’s vaccine made by India’s Serum Institute came after …

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates
3 years, 5 months ago

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates

The Hindu  

The Centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of ₹ 205 and ₹ 215 per dose, respectively, excluding taxes, official sources said. "An order to procure 66 crore more doses of COVID-19 vaccines – Covishield and Covaxin – to …

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates
3 years, 5 months ago

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates

India TV News  

The Centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources informed PTI. "An order to procure 66 crore more doses of COVID-19 vaccines--Covishield and Covaxin--to be supplied between …

Indian govt orders 66 crore covid vaccine doses in biggest procurement: Report
3 years, 5 months ago

Indian govt orders 66 crore covid vaccine doses in biggest procurement: Report

Live Mint  

The Indian government has ordered 660 million vaccine doses for August-December, its largest procurement, local news reports said on Friday, as state authorities and health experts warned that shortages could leave millions vulnerable if coronavirus infections surge again. The federal government aims to inoculate all of the country's estimated 944 million adults by December, a target health experts have said …

Days after Centre's statement, Delhi and other states claim vaccine shortage
3 years, 5 months ago

Days after Centre's statement, Delhi and other states claim vaccine shortage

Hindustan Times  

Delhi has run out of its stocks for the Covishield vaccine against coronavirus disease, news agency PTI reported on Monday night, citing officials familiar with the matter. Manish Sisodia, the deputy chief minister of Delhi, also took to his official handle on Twitter to inform denizens regarding the vaccine shortage in the national capital. Highlighting that Covishield vaccine stocks have …

Maharashtra: Covishield vaccine out of stock at Pune vaccination centres
3 years, 5 months ago

Maharashtra: Covishield vaccine out of stock at Pune vaccination centres

India TV News  

Amid a shortage of COVID-19 vaccines in the state, the Pune mayor on Sunday said that the Covishield will not be available at any vaccination centre under the jurisdiction of Pune Municipal Corporation today. Earlier on Thursday, Brihanmumbai Municipal Corporation had suspended the vaccination drive in Mumbai due to a shortage of stocks. However, Union Health Minister Dr Harsh Vardhan …

Serum Institute urges Centre to take up inclusion of Covishield in vaccination passport with EU
3 years, 5 months ago

Serum Institute urges Centre to take up inclusion of Covishield in vaccination passport with EU

India Today  

The Serum Institute of India has urged the government to take up inclusion of Covishield in the EU Covid-19 Vaccination Passport with the European Union and other countries, saying if not done it will affect students and business travellers, and disrupt the Indian and global economy. However, not including Covishield in the EU Covid-19 Vaccination Passport will not allow Covishield …

Discover Related